TABLE OF CONTENTS
Chapter 1. Virology Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Virology Market - Executive Summary
2.1. Market Size & Forecast – (2019 – 2025) ($M/$B)
2.2. Key Trends & Insights
2.3. Market Share Analysis
2.4. Strategy & Development Scenario
2.5. Market Life Cycle
Chapter 3. Virology Market Landscape
3.1. Value Chain Analysis
3.2. Market Drivers
3.3. Market Restraints/Challenges
3.4. Market Opportunities
3.5. Porter Five Force Model
Chapter 4. Virology Market, By Type - - Market Size, Forecast, Trends & Insights
4.1. Diagnosing Test
4.2. Viral Infection Controlling Methods
4.3. Antiviral Chemotherapy
4.4. Interferons
4.5. Prophylaxis
Chapter 5. Virology Market, By Application - - Market Size, Forecast, Trends & Insights
5.1. Skin and Soft Tissue infections
5.2. Respiratory Tract Infections
5.3. GI Tract Infections
5.4. Urinary Tract Infections
5.5. Eye Infections
5.6. CNS Infections
5.7. STDs/STIs
5.8. Perinatal Diseases
5.9. HPV/HIV
5.10. Influenza
5.11. Others
Chapter 6. Virology Market, By End User - - Market Size, Forecast, Trends & Insights
6.1. Hospitals
6.2. Clinics
6.3. Laboratories
6.4. Diagnostic Centres
6.5. Blood Banks
6.6. Pharmacy
Chapter 7. Virology Market, By Geography - Market Size, Forecast, Trends & Insights
7.1. North America
7.1.2. U.S.
7.1.3. Canada
7.1.4. Mexico
7.2. Europe
7.2.1. Italy
7.2.2. Spain
7.2.3. Russia
7.2.4. Germany
7.2.5. UK
7.2.6. France
7.2.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Japan
7.3.2. South Korea
7.3.3. China
7.3.4. India
7.3.5. Australia & New Zealand
7.3.6. Rest of Asia-Pacific
7.4. Rest of the World
7.4.1. South America
7.4.2. Middle East
7.4.3. Africa
Chapter 8. Virology Market - Company Profiles – (Overview, Product Portfolio, Financials, Developments)
8.1. Company 1
8.2. Company 2
8.3. Company 3
8.4. Company 4
8.5. Company 5
8.6. Company 6
8.7. Company 7
8.8. Company 8
8.9. Company 9
8.10. Company 10
2850
5250
4500
1800